BHD, a reversible male contraceptive agent, effectively induces spermatogenic cell apoptosis and causes abnormalities in seminiferous tubules in vivo at doses of 100 and 500 mg/kg. Additionally, it disrupts the blood-testis barrier and decreases the fertility index in male mice, with effects lasting between two to six weeks post-administration.